About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Slc35e1em1Cya
endonuclease-mediated mutation 1, Cyagen Biosciences
MGI:7586620
Summary 1 genotype
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Slc35e1em1Cya/Slc35e1em1Cya C57BL/6J-Slc35e1em1Cya MGI:7627373


Genotype
MGI:7627373
hm1
Allelic
Composition
Slc35e1em1Cya/Slc35e1em1Cya
Genetic
Background
C57BL/6J-Slc35e1em1Cya
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Slc35e1em1Cya mutation (0 available); any Slc35e1 mutation (38 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
growth/size/body

homeostasis/metabolism
• zinc ion concentrations are increased in epidermal cells of both non-imiquimod and imiquimod treated skin
• mice show decreased susceptibility to imiquimod-induced psoriasis, showing alleviation of psoriasis-like skin lesions, deceased inflammatory cells (CD45+ cells, Langerhans cells, gamma delta T cells, macrophages, and neutrophils) in the epidermis and dermis, and lower expression of cytokines IL-17a and IL-17f

integument
• imiqimod-treated mice show decreased number of proliferating keratinocytes in induced skin lesions
• mice show a less severe imiquimod-induced psoriasis-like phenotype, with decreased keratinocyte proliferation and increased zinc ion levels in the epidermis

cellular
• imiqimod-treated mice show decreased number of proliferating keratinocytes in induced skin lesions





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
09/03/2024
MGI 6.24
The Jackson Laboratory